Advanced glycation end products, galectin-3, matrix metalloproteinase-9 activity in men with heart failure and concomitant benign prostatic hyperplasia with androgen deficiency
| Autor: | Nedzvetsky V.S., Sirenko O.Yu., Tkachenko V.A., Kuryata O.V. |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: | |
| Zdroj: | Medicni perspektivi; Vol. 26 No. 4 (2021); 67-73 Медичні перспективи; Том 26 № 4 (2021); 67-73 Medičnì Perspektivi, Vol 26, Iss 4, Pp 67-73 (2021) |
| ISSN: | 2307-0404 2786-4804 |
| Popis: | The aim was to evaluate serum levels of matrix metalloproteinases-9 activity, advanced glycation end products, galectin-3, C-reactive protein in men with heart failure and benign prostatic hyperplasiawith testosterone deficiency. The testosterone level was determined by immune-enzyme analysis. The content of advanced glycation end products in plasma were analysed by quantitative autofluorescence. The metalloproteinases-9 activity was estimated with fluorometry. The level of galectin-3, C-reactive protein was determined by immune-enzyme analysis. 1stgroup was made up by the men with heart failure and benign prostatic hyperplasia with testosterone deficiency; 2ndgroup – by the men without testosterone deficiency. The men with heart failure and benign prostatic hyperplasia with testosterone deficiency had a significantly higher level of advanced glycation end products, galectin-3, matrix metalloproteinases-9 activity in comparison with men with heart failure without testosterone deficiency (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|